Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HooXi Network was a healthcare technology and digital asset company that specialized in the digitization and securitization of medical and environmental assets. Formed through the acquisition of a private New York-based entity by Liberty Biopharma in 2018, the company aimed to utilize blockchain and artificial intelligence to manage medical intellectual property, healthcare equipment leasing, and carbon credits. Although it was publicly traded on the TSX Venture Exchange and categorized within the biotechnology sector, its primary focus was on financial technology and digital infrastructure for the healthcare industry. The company rebranded as Enlighta Inc. in 2019 and currently operates as a shell entity on the NEX board.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HooXi.